Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction
- PMID: 27522178
- DOI: 10.1016/j.vaccine.2016.08.017
Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction
Abstract
Background: To minimise vaccine-associated risk of intussusception following rotavirus vaccination, Norway adopted very strict age limits for initiating and completing the vaccine series at the time rotavirus vaccination was included in the national immunisation programme, October 2014. Although Norway has a high coverage for routine childhood vaccines, these stringent age limits could negatively affect rotavirus coverage. We documented the status and impact of rotavirus vaccination on other infant vaccines during the first year after its introduction.
Methods: We used individual vaccination data from the national immunisation register to calculate coverage for rotavirus and other vaccines and examine adherence with the recommended schedules. We identified factors associated with completing the full rotavirus series by performing multiple logistic regression analyses. We also evaluated potential changes in uptake and timeliness of other routine vaccines after the introduction of rotavirus vaccine using the Kaplan-Meier method.
Results: The national coverage for rotavirus vaccine achieved a year after the introduction was 89% for one dose and 82% for two doses, respectively. Among fully rotavirus-vaccinated children, 98% received both doses within the upper age limit and 90% received both doses according to the recommended schedule. The child's age at the initiation of rotavirus series and being vaccinated with diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b (DTaP/IPV/Hib) and pneumococcal vaccines were the strongest predictors of completing the full rotavirus series. No major changes in uptake and timeliness of other paediatric vaccines were observed after introduction of rotavirus vaccine.
Conclusions: Norway achieved a high national coverage and excellent adherence with the strict age limits for rotavirus vaccine administration during the first year of introduction, indicating robustness of the national immunisation programme. Rotavirus vaccination did not impact coverage or timeliness of other infant vaccines.
Keywords: Coverage; Rotavirus; Timeliness; Vaccine.
Copyright © 2016. Published by Elsevier Ltd.
Similar articles
-
Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.Hum Vaccin Immunother. 2017 Sep 2;13(9):2102-2110. doi: 10.1080/21645515.2017.1341028. Epub 2017 Jul 11. Hum Vaccin Immunother. 2017. PMID: 28696824 Free PMC article.
-
Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program.Vaccine. 2013 Mar 1;31(11):1523-8. doi: 10.1016/j.vaccine.2013.01.004. Epub 2013 Jan 10. Vaccine. 2013. PMID: 23313652 Free PMC article.
-
Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): impact on the timeliness of uptake of the primary course of DTPa vaccine.Vaccine. 2012 Jul 27;30(35):5293-7. doi: 10.1016/j.vaccine.2012.04.071. Epub 2012 May 7. Vaccine. 2012. PMID: 22575163
-
New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).Ann Pharmacother. 2010 Mar;44(3):515-23. doi: 10.1345/aph.1M468. Ann Pharmacother. 2010. PMID: 20197476 Review.
-
Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Pediatr Infect Dis J. 2009. PMID: 19325452 Review.
Cited by
-
Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC).Hum Vaccin Immunother. 2018 Apr 3;14(4):1027-1034. doi: 10.1080/21645515.2017.1412019. Epub 2018 Jan 18. Hum Vaccin Immunother. 2018. PMID: 29211629 Free PMC article.
-
Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS).Infect Dis Ther. 2020 Dec;9(4):967-980. doi: 10.1007/s40121-020-00345-y. Epub 2020 Oct 6. Infect Dis Ther. 2020. PMID: 33025558 Free PMC article.
-
Rotavirus vaccination and intussusception: a paradigm shift?Hum Vaccin Immunother. 2021 Jan 2;17(1):278-282. doi: 10.1080/21645515.2020.1770035. Epub 2020 Jun 23. Hum Vaccin Immunother. 2021. PMID: 32574098 Free PMC article.
-
Re-evaluation of the cost-effectiveness and effects of childhood rotavirus vaccination in Norway.PLoS One. 2017 Aug 17;12(8):e0183306. doi: 10.1371/journal.pone.0183306. eCollection 2017. PLoS One. 2017. PMID: 28817621 Free PMC article.
-
Established and new rotavirus vaccines: a comprehensive review for healthcare professionals.Hum Vaccin Immunother. 2022 Dec 31;18(1):1870395. doi: 10.1080/21645515.2020.1870395. Epub 2021 Feb 19. Hum Vaccin Immunother. 2022. PMID: 33605839 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical